Abstract:As a member of the ATP-dependent membrane transport proteins, P-Glycoprotein (P-gp) is known to pump substrates out of cells using an ATP-dependent mechanism. The overexpression of P-gp in tumor cells reduces the intracellular drug concentrations, which decreases the efficacy of extensive antitumor drugs and leads to multidrug resistance (MDR) clinically. The combination of anticancer drugs with P-gp inhibitor has been an attractive and promising strategy to reverse MDR in cancer treatment. However, nonspecific or nonselective distribution of P-gp inhibitors to nontarget organs is one of the most fatal shortcomings in clinical application. Thus, there is an urgent need for effective and nontoxic MDR reversal agents, particularly in P-gp–mediated MDR. Traditional Chinese medicine (TCM) natural products may prove less toxic for use in P-gp inhibition to promote MDR reversal. P-gp modulatory effects have been previously demonstrated using selected TCM, including the flavonoid, alkaloid, terpenoid, coumarin, and quinonoid compounds, and some Chinese medicine extracts. Moreover, the approaches for screening active components from TCM are necessary, and these approaches face challenges. At present, the approaches to study the interaction between TCM and P-gp are divided into in vitro, in vivo, and in silico methods. This review will provide an overview and update on the role of TCM in overcoming P-gp–mediated MDR and the approaches to study the interaction between TCM and P-gp. SIGNIFICANCE STATEMENT This review summarized some traditional Chinese medicines identified to have a modulatory effect on P-gp, including flavonoids, alkaloids, terpenoids, coumarins, quinonoid compounds, and some Chinese medicine extracts, and it introduced possible mechanisms. The approaches to study the interaction between TCM and P-gp are divided into in vitro, in vivo, and in silico methods.

Research progress in toxic effects of antitumor drugs based on drug transporter

Research Progress in Toxic Effects of Antitumor Drugs Mediated by Drug Metabolism Enzymes and Isoforms

Advancement in Transporter-Oriented Nanoplatforms for Cancer Therapy

The Effects of Traditional Chinese Medicine on P-Glycoprotein–Mediated Multidrug Resistance and Approaches for Studying the Herb–P-Glycoprotein Interactions

The renal damage and mechanisms relevant to antitumoral drugs

Research progress in drug toxicology based on systems biology

[Research Progress in Toxicology of Molecular Targeted Anticancer Drugs].

Research Progress of Carrier-Free Antitumor Nanoparticles Based on Phytochemicals

Research progress of nanomaterial drug delivery in tumor targeted therapy

The Therapeutic Potential of Targeting ABC Transporters to Combat Multi-Drug Resistance

The mechanisms of multidrug resistance of breast cancer and research progress on related reversal agents

Unveiling tumor immune evasion mechanisms: abnormal expression of transporters on immune cells in the tumor microenvironment

Research progress on the effect of gut and tumor microbiota on antitumor efficacy and adverse effects of chemotherapy drugs

Mechanisms of Myocardial Toxicity of Antitumor Drugs and Potential Therapeutic Strategies: A Review of the Literature

Clinically-Relevant ABC Transporter for Anti-Cancer Drug Resistance

Research Progress in Reversal of Tumor Multi-drug Resistance via Natural Products.

Examination of the emerging role of transporters in the assessment of nephrotoxicity

Research Progress on the Nano-Delivery Systems of Antitumor Drugs

Research Progress of Tumor Microenvironment-responsive Anti-tumor Nano-drug Carriers

Clinical Aspects of Transporter‐Mediated Drug–Drug Interactions

Advances in Nanobiotechnology-Propelled Multidrug Resistance Circumvention of Cancer